Geriatric drug utilisation of psychotropics in Belgian nursing homes

Human Psychopharmacology

Volumn 26, Issue 1, 2011, Pages 12-20

  Azermai, Majda ^a   Elseviers, Monique ^b   Petrovic, Mirko ^a,c   Van Bortel, Luc ^a   Stichele, Robert Vander ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Drug utilisation; Elderly; Homes for the aged; Nursing homes; Older adults; Pharmacoepidemiology; Psychotropic drugs

Indexed keywords

AGENTS AFFECTING METABOLISM; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINESTERASE INHIBITOR; GASTROINTESTINAL AGENT; GINKGO BILOBA EXTRACT; HALOPERIDOL; MEMANTINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NOOTROPIC AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BELGIUM; CHRONIC DRUG ADMINISTRATION; CHRONIC PAIN; COMBINATION CHEMOTHERAPY; CONSTIPATION; CROSS-SECTIONAL STUDY; DEMENTIA; DEPRESSION; DISEASE SEVERITY; DRUG INDICATION; DRUG UTILIZATION; FALL RISK; FEMALE; GERIATRIC PATIENT; HUMAN; INCONTINENCE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NURSING HOME PATIENT; NURSING HOME PERSONNEL; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS;

AGED; AGED, 80 AND OVER; BELGIUM; CROSS-SECTIONAL STUDIES; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTROPIC DRUGS;

EID: 79953250689     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1160     Document Type: Article

References (34)

1. Ballard C, Waite J. 2006. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev (1), CD003476.
2. Ballard C, Hanney M, Theodoulou M, et al. 2009. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 8: 151-157.
3. Bronskill SE, et al. 2004. Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact. J Am Geriatr Soc 52: 749-755. (Pubitemid 38596494)
4. Castle NG, Hanlon JT, Handler SM. 2009. Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. Am J Geriatr Pharmacother 7: 143-150.
5. Draper B, Brodaty H, Low L, et al. 2001. Use of psychotropics in Sydney nursing homes: associations with depression, psychosis, and behavioral disturbances. Int Psychogeriatr 13: 107-120. (Pubitemid 32411154)
6. Elseviers M, Vander Stichele R, Soenen K, Gobert M, Van Bortel L, Van de Voorde C. 2010. Drug utilization in Belgian nursing homes: impact of residents' and institutional characteristics. Pharmacoepidemiol Drug Saf 19: 1041-1048.
7. Garrard J, Chen V, Dowd B. 1995. The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes. Am J Public Health 85: 771-776.
8. Gobert M, D'hooreW. 2005. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatry 20: 712-721.
9. Harrington C, Tompkins C, Curtis M, Grant L. 1992. Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist 32: 822-833.
10. HCFA. 1992. Medicaid State Operations Manual: Provider Certification, Transmittal 250. Washington, DC, United States Department of health and human services, health care financing: administration.
11. Holmquist IB, Svensson B, Hoglund P. 2003. Psychotropic drugs in nursing-and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 59: 669-676. (Pubitemid 37494537)
12. Hughes CM, Lapane KL. 2005. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been? Drugs Aging 22: 339-351.
13. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H. 2005. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 331: 321-327.
14. Katz S, Akpom CA. 1976. A measure of primary sociobiological functions. Int J Health Serv 6: 493-508.
15. Lader M. 2008. Effectiveness of benzodiazepines: do they work or not? Expert Rev Neurother 8: 1189-1191.
16. Landi F, Onder G, Cesari M, Barillaro C, Russo A, Bernabei R. 2005. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 60: 622-626. (Pubitemid 40847931)
17. Mann E, Kopke S, Haastert B, Pitkala K, Meyer G. 2009. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr 9: 18.
18. Mittmann N, Herrmann N, Einarson T, et al. 1997. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord 46: 191-217. (Pubitemid 28165944)
19. Moret C, Isaac M, Briley M. 2009. Problems associated with long-term treatment with selective serotonin reuptake inhibitors. J Psychopharmacol 23: 967-974.
20. Mottram P, Wilson K, Strobl J. 2006. Antidepressants for depressed elderly. Cochrane Database Syst Rev (1), CD003491.
21. Nelson JC, Thase ME, Khan A, Nelson JC. 2008. Are antidepressants effective? What's a clinician to think? J Clin Psychiatry 69: 1014-1015.
22. National Institute for Health and Clinical Excellence (NICE). 2009. Alzheimer's disease: donepezil, galantamine, rivastigmine (review) and memantine: guidance. http://www.nice.org.uk/nicemedia/live/11600/45349/45349. pdf. Accessed November 2009.
23. Nijk RM, Zuidema SU, Koopmans RT. 2009. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. Int Psychogeriatr 21: 485-493.
24. Petrovic M, De PP, Van BL. 2005. Pharmacotherapy of depression in old age. Acta Clin Belg 60: 150-156. (Pubitemid 43339170)
25. Siegler EL, Capezuti E, Maislin G, Baumgarten M, Evans L, Strumpf N. 1997. Effects of a restraint reduction intervention and OBRA '87 regulations on psychoactive drug use in nursing homes. J Am Geriatr Soc 45: 791-796.
26. Sim MG, Khong E, Wain TD. 2007. The prescribing dilemma of benzodiazepines. Aust Fam Physician 36: 923-926.
27. Snowden M, Roy-Byrne P. 1998. Mental illness and nursing home reform: OBRA-87 ten years later. Omnibus Budget Reconciliation Act. Psychiatr Serv 49: 229-233. (Pubitemid 28071434)
28. Sorensen L, Foldspang A, Gulmann NC, Munk-Jorgensen P. 2001. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 16: 147-154. (Pubitemid 32166305)
29. Sterke CS, Verhagen AP, van Beeck EF, van der Cammen TJ. 2008. The influence of drug use on fall incidents among nursing home residents: a systematic review. Int Psychogeriatr 20: 890-910.
30. Svarstad BL, Mount JK. 2001. Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc 49: 1673-1678. (Pubitemid 34007995)
31. van der Hooft CS, et al. 2008. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 66: 276-282.
32. van Dijk KN, de Vries CS, van den Berg PB, Brouwers JR, de Jong-van den Berg LT. 2000. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol 55: 765-771.
33. Vander Stichele R, Van de Voorde C, Elseviers M, et al. 2006. Medication use in Belgian rest and nursing homes. Health Services Research. KCE reports 47 A(D/2006/10.273/61).
34. Wancata J, Benda N, Meise U, Muller C. 1997. Psychotropic drug intake in residents newly admitted to nursing homes. Psychopharmacology (Berl) 134: 115-120. (Pubitemid 27522566)